Article

Intrapleural injection of Folactis promotes regression of malignant pleural effusion: a case of malignant pleural mesothelioma and the review of literatures

2025-01-20

Abstract excerpt

<title>Abstract</title> <p>Malignant pleural mesothelioma is an aggressive and lethal malignancy that arises from the mesothelial cells lining the pleura. Diagnosis commonly occurs at an advanced stage, rendering patients unsuitable for surgical intervention. Pharmacological interventions have shown limited success in controlling the disease. In the present study, we present a case of malignant pleural mesothelio...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 03f162b1-edd5-5012-b92e-81ce552c7d8f
DOI: 10.21203/rs.3.rs-5749611/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Intrapleural injection of Folactis promotes regression of malignant pleural effusion: a case of malignant pleural mesothelioma and the review of literaturesDOI 10.21203/rs.3.rs-5749611/v1Read

[Malignant pleural mesothelioma: 2013 state of the art].Semantic proximity Read

Management of malignant pleural mesothelioma.Semantic proximity Read

Multimodality treatment of malignant pleural mesotheliomaSemantic proximity Read

Secreted and Tissue miRNAs as Diagnosis Biomarkers of Malignant Pleural MesotheliomaSemantic proximity Read

[Correlation between the Expression of PD-L1 in Pleural Effusion of Lung Adenocarcinoma and the Clinicopathological Features and Molecular Changes].Semantic proximity Read

A phase II study of amrubicin as palliative chemotherapy for previously treated malignant pleural mesotheliomaSemantic proximity Read

Genome-wide profile of pleural mesothelioma versus parietal and visceral pleura: the emerging gene portrait of the mesothelioma phenotype.Semantic proximity Read

Pleural effusion in lung cancer: more questions than answers.Semantic proximity Read

Case report: targeted therapy of malignant pleural mesothelioma with anaplastic lymphoma kinase receptor tyrosine kinase gene fusion mutation by crizotinib.Semantic proximity Read

Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti–PD-1 + Antiangiogenesis in Malignant Pleural MesotheliomaSemantic proximity Read

Prognosis of EGFR-mutant Lung Adenocarcinoma Patients With Malignant Pleural Effusion Receiving First-line EGFR-TKI Therapy Without Pleurodesis: A Single-institute Retrospective Study.Semantic proximity Read

Current State of Art Therapy for MPM and Future Options Focus on ImmunotherapySemantic proximity Read